Getinge Industrier AB
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage so… Read more
Getinge Industrier AB (GNGBY) - Net Assets
Latest net assets as of December 2025: $29.49 Billion USD
Based on the latest financial reports, Getinge Industrier AB (GNGBY) has net assets worth $29.49 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($56.51 Billion) and total liabilities ($27.01 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $29.49 Billion |
| % of Total Assets | 52.2% |
| Annual Growth Rate | 10.2% |
| 5-Year Change | 17.15% |
| 10-Year Change | 41.01% |
| Growth Volatility | 13.66 |
Getinge Industrier AB - Net Assets Trend (2002–2025)
This chart illustrates how Getinge Industrier AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Getinge Industrier AB (2002–2025)
The table below shows the annual net assets of Getinge Industrier AB from 2002 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $29.49 Billion | -11.19% |
| 2024-12-31 | $33.21 Billion | +9.23% |
| 2023-12-31 | $30.40 Billion | -0.16% |
| 2022-12-31 | $30.45 Billion | +20.96% |
| 2021-12-31 | $25.18 Billion | +17.17% |
| 2020-12-31 | $21.49 Billion | +2.45% |
| 2019-12-31 | $20.97 Billion | +6.71% |
| 2018-12-31 | $19.66 Billion | -0.76% |
| 2017-12-31 | $19.81 Billion | -5.31% |
| 2016-12-31 | $20.92 Billion | +6.75% |
| 2015-12-31 | $19.59 Billion | +4.81% |
| 2014-12-31 | $18.69 Billion | +12.89% |
| 2013-12-31 | $16.56 Billion | +8.95% |
| 2012-12-31 | $15.20 Billion | +3.85% |
| 2011-12-31 | $14.64 Billion | +10.48% |
| 2010-12-31 | $13.25 Billion | +5.46% |
| 2009-12-31 | $12.56 Billion | +17.67% |
| 2008-12-31 | $10.68 Billion | +61.20% |
| 2007-12-31 | $6.62 Billion | +10.29% |
| 2006-12-31 | $6.00 Billion | +11.59% |
| 2005-12-31 | $5.38 Billion | +26.04% |
| 2004-12-31 | $4.27 Billion | +20.94% |
| 2003-12-31 | $3.53 Billion | +11.79% |
| 2002-12-31 | $3.16 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Getinge Industrier AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1819.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $21.50 Billion | 73.07% |
| Common Stock | $136.00 Million | 0.46% |
| Other Components | $7.79 Billion | 26.47% |
| Total Equity | $29.43 Billion | 100.00% |
Getinge Industrier AB Competitors by Market Cap
The table below lists competitors of Getinge Industrier AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Methanex Corporation
NASDAQ:MEOH
|
$3.42 Billion |
|
Universal Scientific Industrial Shanghai Co Ltd
SHG:601231
|
$3.42 Billion |
|
The Phoenix Mills Limited
NSE:PHOENIXLTD
|
$3.43 Billion |
|
AllianceBernstein Holding L.P.
NYSE:AB
|
$3.43 Billion |
|
Sime Darby Plantation Berhad
OTCGREY:SDPNF
|
$3.42 Billion |
|
Riocan REIT
PINK:RIOCF
|
$3.42 Billion |
|
Group 1 Automotive Inc
NYSE:GPI
|
$3.41 Billion |
|
Allreal Holding
SW:ALLN
|
$3.41 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Getinge Industrier AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 33,005,000,000 to 29,429,000,000, a change of -3,576,000,000 (-10.8%).
- Net income of 2,258,000,000 contributed positively to equity growth.
- Dividend payments of 1,177,807,424 reduced retained earnings.
- Other comprehensive income decreased equity by 5,752,000,000.
- Other factors increased equity by 1,095,807,424.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.26 Billion | +7.67% |
| Dividends Paid | $1.18 Billion | -4.0% |
| Other Comprehensive Income | $-5.75 Billion | -19.55% |
| Other Changes | $1.10 Billion | +3.72% |
| Total Change | $- | -10.83% |
Book Value vs Market Value Analysis
This analysis compares Getinge Industrier AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.18x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.34x to 0.18x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $14.26 | $19.07 | x |
| 2003-12-31 | $15.94 | $19.07 | x |
| 2004-12-31 | $19.06 | $19.07 | x |
| 2005-12-31 | $23.96 | $19.07 | x |
| 2006-12-31 | $27.01 | $19.07 | x |
| 2007-12-31 | $29.50 | $19.07 | x |
| 2008-12-31 | $47.63 | $19.07 | x |
| 2009-12-31 | $49.60 | $19.07 | x |
| 2010-12-31 | $52.31 | $19.07 | x |
| 2011-12-31 | $57.79 | $19.07 | x |
| 2012-12-31 | $60.01 | $19.07 | x |
| 2013-12-31 | $65.40 | $19.07 | x |
| 2014-12-31 | $72.56 | $19.07 | x |
| 2015-12-31 | $75.97 | $19.07 | x |
| 2016-12-31 | $84.82 | $19.07 | x |
| 2017-12-31 | $77.31 | $19.07 | x |
| 2018-12-31 | $70.50 | $19.07 | x |
| 2019-12-31 | $75.25 | $19.07 | x |
| 2020-12-31 | $77.19 | $19.07 | x |
| 2021-12-31 | $90.87 | $19.07 | x |
| 2022-12-31 | $110.28 | $19.07 | x |
| 2023-12-31 | $110.75 | $19.07 | x |
| 2024-12-31 | $121.18 | $19.07 | x |
| 2025-12-31 | $108.05 | $19.07 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Getinge Industrier AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.67%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.46%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 1.92x
- Recent ROE (7.67%) is below the historical average (12.91%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 19.69% | 7.20% | 0.91x | 3.00x | $305.88 Million |
| 2003 | 22.03% | 8.49% | 0.76x | 3.41x | $424.66 Million |
| 2004 | 27.20% | 10.54% | 0.87x | 2.95x | $725.74 Million |
| 2005 | 21.45% | 9.58% | 0.82x | 2.74x | $607.66 Million |
| 2006 | 20.96% | 9.65% | 0.82x | 2.65x | $655.70 Million |
| 2007 | 18.69% | 7.50% | 0.72x | 3.48x | $573.20 Million |
| 2008 | 14.31% | 7.91% | 0.58x | 3.10x | $458.80 Million |
| 2009 | 15.24% | 8.38% | 0.61x | 2.99x | $657.20 Million |
| 2010 | 17.22% | 10.27% | 0.64x | 2.62x | $954.70 Million |
| 2011 | 17.31% | 11.57% | 0.53x | 2.84x | $1.07 Billion |
| 2012 | 16.62% | 10.40% | 0.56x | 2.83x | $1.00 Billion |
| 2013 | 13.82% | 9.04% | 0.57x | 2.68x | $631.90 Million |
| 2014 | 7.81% | 5.37% | 0.50x | 2.88x | $-401.20 Million |
| 2015 | 7.24% | 4.60% | 0.57x | 2.77x | $-530.30 Million |
| 2016 | 5.79% | 3.99% | 0.54x | 2.69x | $-862.80 Million |
| 2017 | 7.10% | 6.12% | 0.53x | 2.17x | $-562.40 Million |
| 2018 | -5.04% | -4.00% | 0.56x | 2.26x | $-2.89 Billion |
| 2019 | 5.96% | 4.60% | 0.59x | 2.18x | $-827.60 Million |
| 2020 | 15.41% | 10.86% | 0.66x | 2.14x | $1.14 Billion |
| 2021 | 12.00% | 10.98% | 0.61x | 1.80x | $495.10 Million |
| 2022 | 8.29% | 8.80% | 0.54x | 1.73x | $-512.80 Million |
| 2023 | 8.00% | 7.58% | 0.59x | 1.78x | $-604.60 Million |
| 2024 | 4.96% | 4.71% | 0.54x | 1.94x | $-1.66 Billion |
| 2025 | 7.67% | 6.46% | 0.62x | 1.92x | $-684.90 Million |
Industry Comparison
This section compares Getinge Industrier AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Getinge Industrier AB (GNGBY) | $29.49 Billion | 19.69% | 0.92x | $3.42 Billion |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |